Less than a week until #HIVWOMENAFRICA commences. Don't miss this hybrid workshop dedicated to enhancing the quality of life for women living with #HIV and reducing viral transmissions in Africa 👉bit.ly/48iFPTW

Session 2 is underway focusing on HIV prevention; New Prevention Regimens and How they Affect HIV care, updates on PrEP and Breastfeeding Practices Among Women Living with HIV. #HIVWOMENAFRICA

Happenning now! The Pregnancy, Breastfeeding and Contraception Session, exploring the Modern Contraceptive Options for Women on ART, and Does U=U Apply for Breastfeeding? #HIVWOMENAFRICA

It’s a wrap for the inaugural African workshop on Women & HIV. So many brilliant presentations, beautiful smiles, passionate people & candid testimonials. >400 delegates from 19 countries. Much food for thought. To be continued in Feb 2025, hope to see u there #HIVWOMENAFRICA

Glad to hear this 🙏

Her project will be an extension to the Pregnancy Infant and Maternal Health Outcome (PRIMO), with Friday Saidi as her primary mentor. She will explore “facilitators and barriers to long-acting injectable PrEP use among pregnant and breastfeeding women”.

This Thursday and Friday, we held a protocol training session for the O-PrEP study, a crucial initiative aimed at optimizing PrEP regimens for pregnant women in sub-Saharan Africa.

Opportunity to join our team : globalhealth.unc.edu/malawi/malawi-…

Excited to be speaking at the 16th International Workshop on Pediatrics & HIV from 19-20 July 2024 in Munich, Germany! Join the Discussion on What is New on Cabotegravir (CAB-LA) in Pregnancy: Progress on Implementation and Surveillance of Pregnancy Outcomes #HIVPED

I am honored to have received the Honorary Lynne Mofenson Award for the Outstanding presentation at the International HIV and Pediatrics Workshop. This award includes a full travel scholarship that will allow me to attend the 2025 workshop in Kigali, Rwanda. #HIVPED

Warm welcome to our new #BMCPregnancyChildbirth Editorial Board Members Friday Saidi and Smriti Prasad. We are looking forward to working with you. Interested in joining #BMCPregnancyChildbirth? To find out more visit <…pregnancychildbirth.biomedcentral.com/about/join-us>

“Oral PrEP maybe be altering the vaginal microbiota of pregnant women and predisposing them to the risk of preterm birth. A larger study is needed to confirm the findings.” says Friday Saidi from the UNC Project - Malawi at #HIVR4P2024

African Women & #HIV 2025 conference. Call for abstracts. Please get yours in as submission deadline is fast approaching. Details👇🏿👇🏿👇🏿 Academic Medical Education SWIFT Dr Shema Tariq Legacy Account (on LinkedIn) Susan Cole-Haley FRSA Salamander Trust Making Waves @ICW_Global @thewellproject 🙏🏾😊

Sharing our latest publication: a systematic review and narrative synthesis on the predictors of maternal HIV acquisition in sub-Saharan Africa. lnkd.in/dPwj9dky

Today we remember Professor James Gita Hakim on the 4th anniversary of his passing. He was a wonderful mentor and an inspiration to many people in the medical fraternity . May he rest in peace. 🙏🙏

I am honored to have moderated a session on maternal and child health research at the ongoing #CROI2025 . The session was well-attended, featuring great presentations and engaging discussions. I am grateful for the opportunity to facilitate this important conversation!

On Monday, Dr. Friday Saidi moderated one of the sessions at the 2025 Conference for Retroviruses and Opportunistic Infections in San Francisco! 🌟 The discussion included: ▶️ Maternal Tenofovir for preventing infant Hepatitis B ▶️Home visit strategies to promote family health

I have been featured in the HIV Prevention Trials Network (HPTN) April newsletter. Check out my guilty pleasure 😂😂😂😂 hptn.org/about/conversa…

New review: long-acting HIV drugs are safe for pregnant/breastfeeding women, with more trials including them. Injectable PrEP is entering maternal health. Policy and cost challenges remain. Read: rdcu.be/eAXGB #HIV #MaternalHealth #LongActingART

Our new Lancet correspondence urges prioritizing pregnant & breastfeeding women in HIV prevention using the “Two for Two” approach: just 2 LEN injections over 6 months to protect both mom & baby. thelancet.com/journals/lance…